NDC 0641-6014-01 - Diltiazem Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0641-6014
- Requested NDC
- 0641-6014-01
- Package NDCs from labels
- 0641-6014-01, 0641-6014-10
- Manufacturer
- Hikma Pharmaceuticals USA Inc.
- Effective date
- 2024-04-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Diltiazem Hydrochloride Injection Rx Only | Hikma Pharmaceuticals USA Inc. | 2024-04-09 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0641-6014-01 | Diltiazem Hydrochloride | 10 mL in 1 VIAL | INJECTION | 10 | 5 | |
| 0641-6014-10 | Diltiazem Hydrochloride | 10 in 1 CARTON | INJECTION | 10 | 5 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0641-6014-01 | ML - Milliliter | 0641-6014 | ca46bccc-cb32-4db4-8a74-e9df3e094fea | 1 | 2012-07-24 |
| 0641-6014-10 | ML - Milliliter | 0641-6014 | a2385cab-109e-4588-9bdc-989af5b5daf2 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| DILTIAZEM HYDROCHLORIDE | ACTIVE INGREDIENT | OLH94387TE | DILTIAZEM HYDROCHLORIDE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 | |
| DILTIAZEM | ACTIVE MOIETY | EE92BBP03H | DILTIAZEM HYDROCHLORIDE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | DILTIAZEM HYDROCHLORIDE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | DILTIAZEM HYDROCHLORIDE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 | |
| SODIUM CITRATE | INACTIVE INGREDIENT | 1Q73Q2JULR | DILTIAZEM HYDROCHLORIDE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | DILTIAZEM HYDROCHLORIDE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 | |
| SORBITOL | INACTIVE INGREDIENT | 506T60A25R | DILTIAZEM HYDROCHLORIDE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | DILTIAZEM HYDROCHLORIDE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Endocrinpath | ALFALFA, BORAGO OFFICINALIS, CALCAREA CARBONICA, CEANOTHUS AMERICANUS, CITRICUM ACIDUM, FUCUS VESICULOSUS, GINKGO BILOBA, GLANDULA SUPRARENALIS SUIS, GLYCYRRHIZA GLABRA, HYDROCOTYLE ASIATICA, HYPOTHALAMUS (BOVINE), KALI PHOSPHORICUM, PANCREAS SUIS, PHYTOLACCA DECANDRA, PITUITARUM POSTERIUM (BOVINE), SARSAPARILLA (SMILAX REGELII), SILICEA, SYZYGIUM JAMBOLANUM, TARAXACUM OFFICINALE, THYROIDINUM (BOVINE) | Energetix Corporation | 70f84941-b8a1-48f4-9c05-554e554f0049 | 2025-07-11 | Warnings | XF417D3PSL |
| Sterile Water | STERILE WATER | Nephron Pharmaceuticals Corporation | bc04a883-babc-87a6-e053-2995a90a3dfd | 2025-07-11 | Warnings, Adverse reactions | 059QF0KO0R |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | Belleview Biosciences LLC | 3245e0e5-5e7f-c3f7-e063-6394a90ac258 | 2025-07-07 | Adverse reactions | 1Q73Q2JULR XF417D3PSL |
| Plaque identifying | PLAQUE IDENTIFYING | Shenzhen Yagao Technology Co., Ltd. | 37eeb656-22f1-7372-e063-6394a90ad041 | 2025-06-19 | Warnings | 059QF0KO0R 506T60A25R |
| diltiazem hydrochloride | DILTIAZEM HYDROCHLORIDE | Ingenus Pharmaceuticals, LLC | 355f560a-8ebb-4661-ad74-2a22f707d7f8 | 2025-06-17 | Warnings, Adverse reactions | OLH94387TE |
| TIADYLT ER | DILTIAZEM HYDROCHLORIDE | Bryant Ranch Prepack | b4b4e53e-fc99-4f34-abc2-57e4f28aff84 | 2025-06-13 | Warnings, Adverse reactions | OLH94387TE |
| diltiazem hydrochloride | DILTIAZEM HYDROCHLORIDE | Bryant Ranch Prepack | c044f774-783f-4920-a8a1-6d4b1b3820c1 | 2025-06-11 | Warnings, Adverse reactions | OLH94387TE |
| Cartia XT | DILTIAZEM HYDROCHLORIDE | Bryant Ranch Prepack | de671934-25a8-4df6-b7a1-97e0337e9e2b | 2025-06-02 | Warnings, Adverse reactions | OLH94387TE |
| Diltiazem Hydrochloride | DILTIAZEM HYDROCHLORIDE | Teva Pharmaceuticals USA, Inc. | 69ca7cae-fdf3-413a-900b-95cf6e9e7b63 | 2025-05-30 | Warnings, Adverse reactions | OLH94387TE |
| Sterile Water | WATER | Henry Schein, Inc. | 88403fcf-a276-42c0-88b6-bd84a720b564 | 2025-05-29 | Warnings, Adverse reactions | 059QF0KO0R |
| Insecticides/Pest/Food Additives Detox | BOLDO, CARDUUS MARIANUS, CHELIDONIUM MAJUS, PETROSELINUM SATIVUM, TARAXACUM OFFICINALE, ARSENICUM ALBUM, BISPHENOL A, COBALTUM METALLICUM, CUPRUM METALLICUM, GLYPHOSATE, IODIUM, LYCOPODIUM CLAVATUM, PHOSPHORICUM ACIDUM, SELENIUM METALLICUM, ZINCUM METALLICUM, ASPARTAME, BENZALKONIUM CHLORIDE, FORMALINUM, METHYLENE CHLORIDE, METHYLPARABEN, PROPYLPARABEN, SODIUM BENZOATE, SODIUM CITRATE, TITANIUM DIOXIDE, ZINCUM OXYDATUM | Dr. Donna Restivo DC | b5778211-0e3e-44ef-bd65-a76a68cf1504 | 2025-05-23 | Warnings | 1Q73Q2JULR |
| Diltiazem hydrochloride | DILTIAZEM HYDROCHLORIDE | Sun Pharmaceutical Industries, Inc. | 976d9dd0-4f11-4439-b84e-0c0f0e018d8b | 2025-05-22 | Warnings, Adverse reactions | OLH94387TE |
| Eyesaline Emergency Eyewash | STERILE EYESALINE EYEWASH | Honeywell Safety Products USA, Inc. | 2d567518-4c54-7448-e063-6294a90a3e64 | 2025-05-14 | Warnings | 059QF0KO0R |
| Diltiazem hydrochloride | DILTIAZEM HYDROCHLORIDE | Viona Pharmaceuticals Inc | 43cffe12-304a-4e15-9512-94f812188f1a | 2025-05-05 | Warnings, Adverse reactions | OLH94387TE |
| TIADYLT ER | DILTIAZEM HYDROCHLORIDE | Zydus Pharmaceuticals (USA) Inc. | 1278cd76-b8e9-42d9-ad19-6858e72cf9f2 | 2025-05-02 | Warnings, Adverse reactions | OLH94387TE |
| TIADYLT ER | DILTIAZEM HYDROCHLORIDE | Zydus Lifesciences Limited | d88e3546-3984-4dc9-893a-a29e95804550 | 2025-05-02 | Warnings, Adverse reactions | OLH94387TE |
| Diltiazem Hydrochloride | DILTIAZEM HYDROCHLORIDE | Coupler LLC | 3418eb02-117e-a71a-e063-6394a90a826e | 2025-05-01 | Warnings, Adverse reactions | OLH94387TE |
| diltiazem hydrochloride | DILTIAZEM HYDROCHLORIDE | Zydus Pharmaceuticals (USA) Inc. | 1e2f2025-0350-40c4-ab42-3b57f3d105a6 | 2025-05-01 | Warnings, Adverse reactions | OLH94387TE |
| Diltiazem Hydrochloride | DILTIAZEM HYDROCHLORIDE | Actavis Pharma, Inc. | 178eec1f-1d4d-4a38-b66a-d3ba3de06c3d | 2025-05-01 | Warnings, Adverse reactions | OLH94387TE |
| diltiazem hydrochloride | DILTIAZEM HYDROCHLORIDE | Zydus Lifesciences Limited | fe790439-85d4-4cd8-a385-149ea3442a38 | 2025-05-01 | Warnings, Adverse reactions | OLH94387TE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.